TYLENOL WITH NAPROXEN (Acetaminophen; Naproxen Sodium) Patent Expiration, LOE Window & CMS Spending

TYLENOL WITH NAPROXEN (Acetaminophen; Naproxen Sodium) by Kenvue Brands: FDA Orange Book LOE 2029-07-24, 0 AB generics, $0 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorKenvue Brands
FDA Application & PathwayN219962 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2029-07-24
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel